Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2010
05/19/2010CN101066315B Medicine for treating duck's bacillosis
05/19/2010CN101066263B Use of baicalein as antifungal medicine synergist
05/19/2010CN101063103B Hainan sporic scorpion antibiotic and preparation method and application
05/19/2010CN101062202B Agent for preventing and treating common cold
05/19/2010CN101057901B Traditional Chinese medicinal composition for curing hepatitis
05/19/2010CN101049342B Method for extracting effective portion, and new application for anti AIDS
05/19/2010CN101049320B Buccal tablets of extractive of propolis alcohol
05/19/2010CN101032596B Medicine for treating respiratory tract diseases for chickens and its preparing process
05/19/2010CN101028393B Chinese-medicinal decoction for treating ribbon bleb
05/19/2010CN101028077B Method for preparing cactus nutrient dried brown rice vermicelli
05/19/2010CN101024665B Decarboxylated FR-008 derivative polyketone antibiotic and use thereof
05/19/2010CN101023990B Chinese readymade medicine for treating exogenous disease
05/19/2010CN101020072B Deodorizing bacteriostatic mildewproof powder preparation
05/19/2010CN101015326B Wax-free aged honeycomb beverage and its preparing process
05/19/2010CN101007136B Preparation method of a novel soft capsule for clearing heat and detoxifying
05/19/2010CN101003550B 8- halogenated adenine nucleotide compound , synthetic method, medical application
05/19/2010CN101002909B Antiviral traditional Chinese medicine, its preparing method and quality control method
05/19/2010CN101002874B Compound traditional Chinese medicine with antibiotic and anti-inflammatory function, and its preparing method
05/19/2010CN101002782B Medicine composition containing ceftin cyclodextrin clathrate, and its preparing method
05/19/2010CN100998592B Microemulsion containing matrine
05/18/2010USRE41339 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718651 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope
05/18/2010US7718623 Immunostimulatory oligonucleotide that induces interferon alpha
05/18/2010US7718605 conjugated drug comprising nerve growth factor linked to a steroid; for tissue-targeted therapy; treating pain
05/18/2010US7718401 Expression of HIV polypeptides and production of virus-like particles
05/18/2010US7718391 Assays for identifying modulators of rhomboid polypeptides
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2387536C Rate-controlled particles
05/18/2010CA2383357C Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues
05/18/2010CA2347926C Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds
05/18/2010CA2339667C Method of using tetracycline compounds to enhance interleukin-10 production
05/18/2010CA2302808C 50 human secreted proteins
05/14/2010WO2010054093A1 Formulations for the treatment of acute herpes zoster pain
05/14/2010WO2010054042A2 Dimethylphenoxy modulators of viral protease activity and/or parasitic enzyme activity
05/14/2010WO2010053978A2 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/14/2010WO2010053942A1 Methods for treating hepatitis c virus infection
05/14/2010WO2010053877A2 Mhc ii associated protein and uses thereof
05/14/2010WO2010053583A2 Small molecule cd4 mimetics and uses thereof
05/14/2010WO2010053350A1 Inhibition of viral infection and replication by mesenchymal stem cells (msc) and msc-derived products
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010052836A1 Aqueous solution of antimicrobial agent and method for producing same
05/14/2010WO2010052575A2 Ngna compositions and methods of use
05/14/2010WO2010051667A1 Pharmaceutical compositions comprising cyclic peptide nanotubes and the uses thereof
05/14/2010WO2010051634A1 Human progenitor t-cells
05/14/2010WO2010033292A9 Method for medical treatment utilizing l-glutathione
05/14/2010WO2010033043A8 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof
05/14/2010WO2010025438A9 Methods of treatment using single doses of oritavancin
05/14/2010WO2010025267A3 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
05/14/2010WO2010014739A3 Heterocyclic modulators of tgr5
05/14/2010WO2010011343A3 Methods for treating viral disorders
05/14/2010WO2010005572A3 Alpha-keto heterocycles as faah inhibitors
05/14/2010WO2010003053A3 Hsv-2 peptides for stimulation of cytotoxic t lymphocytes
05/14/2010WO2009153434A3 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response
05/14/2010WO2009151496A4 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells
05/14/2010WO2009134616A8 Novel inhibitors of hepatitis c virus replication
05/14/2010CA2742712A1 Methods and systems for treating and controlling oral periopathogens
05/14/2010CA2742622A1 Human progenitor t-cells
05/14/2010CA2742603A1 Formulations for the treatment of acute herpes zoster pain
05/14/2010CA2742531A1 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/13/2010US20100121255 Compound
05/13/2010US20100120901 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
05/13/2010US20100120896 Once-A-Day RNA-Polymerase inhibiting and elongation factor G (EF-G) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureus
05/13/2010US20100120894 Intracellular DNA receptor
05/13/2010US20100120872 Organic compounds and their uses
05/13/2010US20100120847 Styrylquinolines, their process of preparation and their therapeutic uses
05/13/2010US20100120844 Tetrahydroisoquinoline compound
05/13/2010US20100120826 Method of inducing cytokine biosynthesis
05/13/2010US20100120825 Method of treating mollescum contagiosum
05/13/2010US20100120821 Method of treating genital or peri-anal warts
05/13/2010US20100120820 Method of treating actinic keratosis
05/13/2010US20100120795 Powders for reconstitution
05/13/2010US20100120786 Piperazine Derivatives
05/13/2010US20100120760 Benzofuran-carboxamide derivatives as antiviral agents
05/13/2010US20100120753 Anti-Infective Agents
05/13/2010US20100120721 Substituted piperidinophenyl oxazolidinones
05/13/2010US20100120716 Macrocyclic hepatitis c serine protease inhibitors and uses therefor
05/13/2010US20100120715 Beta-lactamase inhibitors
05/13/2010US20100120704 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
05/13/2010US20100120701 Compositions and Methods For Engineering Probiotic Yeast
05/13/2010US20100120690 Polypeptides Having Antimicrobial Activity and Polynucleotides Encoding Same
05/13/2010US20100120680 Method of treating hepatitis c virus
05/13/2010US20100120675 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof
05/13/2010US20100120673 Bacteriophage lysins for bacillus anthracis
05/13/2010US20100120672 cyclic peptide compounds
05/13/2010US20100120671 Novel antimicrobial agents
05/13/2010US20100120070 Precise efficacy assay methods for active agents including chemotherapeutic agents
05/13/2010US20100119594 Nourin and nourin antagonists
05/13/2010US20100119588 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza
05/13/2010US20100119570 Solid Pharmaceutical And Vaccine Dose
05/13/2010US20100119558 Ngna compositions and methods of use
05/13/2010US20100119555 Methods and Compositions for the Treatment and Diagnosis of Cancer
05/13/2010US20100119553 Helicobacter pylori sialic acid binding adhesin, SabA and sabA - gene
05/13/2010US20100119552 Purification of vaccinia viruses using hydrophobic interaction chromatography
05/13/2010US20100119551 Methods and reagents for vaccination which generate a CD8 T cell immune response
05/13/2010US20100119550 Recombinant multivalent vaccine
05/13/2010US20100119549 Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
05/13/2010US20100119547 Recombinant Parainfluenza Virus Expression Systems And Vaccines
1 ... 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 ... 1798